Emma shares her vision for healthcare, how AI is reshaping pharma and why access to innovation must be faster and fairer in Europe.

Wellness trends are outpacing science and endangering lives. As trust in traditional medicine erodes, pharma must step in to correct the narrative.

Graham Clark, CEO, Phastar, explores the current state of play in clinical research, the future of AI in the field and values-based business.

In a departure from years past, Cannes Lions 2025 saved a sizable percentage of their praise for companies in the pharma space.

How can AI expand healthcare access without losing the human touch? Philips’ CMO Dr Carla Goulart Peron shares all.

When every second of a healthcare professional’s time counts, what content truly earns their attention – disease awareness or product promotion?

Four medical affairs leaders reveal what’s working (and what’s not) when it comes to engaging time-starved HCPs in 2025.

Discover Andrew Cooper’s passion for optimising clinical trials with AI, driving innovation and building a culture of teamwork and purpose.

Nurse practitioners and physician assistants are vital players in US healthcare, yet the industry often overlooks them.

Dr Tami Nussbaum, shares why she left medicine for pharma, the challenges of rare disease and how she avoids burnout.

Kate Lenik shares her journey into HR, the evolving pharma workplace, and the secrets behind Chiesi’s award-winning culture.

How pharma could shift from curing disease to promoting healthy ageing through epigenetics, the microbiome and antimicrobial innovation.

Women’s health remains chronically underfunded, yet closing the gap could unlock huge value for women and the global economy.

Prof Alexander Egeberg, Vice President, Head of Global Medical Affairs, LEO Pharma, reveals how the company is tackling unmet needs in dermatology.

How can the pharmaceutical industry ‘Accelerate Action’ on gender parity this International Women’s Day? Find out now.

Find out what the Senior Vice President, EU & International, Rare Diseases, Chiesi Group, thinks the pharma industry should consider on Rare Disease Day.

Jaime Manzanera, EMEA Brand Director, Oncology, Eisai, shares his perspective on maximising ROI in pharmaceutical marketing and more.

Recall matters when it comes to medical content. Find out how knowledge can be better retained through interactive medical education.

Dr Matthew Hickling explores the science behind beauty, his role in aesthetics and the opportunities shaping the future of the field.

There are many pillars of medical affairs, but field teams are where the action happens. How do you build teams that deliver results?

Attention is the new currency in pharma marketing. With HCPs overwhelmed by information, delivering engaging content is crucial to standing out.

In the pharmaceutical industry, improving customer experience has become the goal, but it’s time to look at it in a new way.

Roxana Redis, Associate Science Director of Advanced Modalities, Charles River Laboratories, talks about the exciting field of RNA.

In the final quarter of the year, how can pharmaceutical teams make their final budget decisions count?

The former Baxter leader talks about the founding of Vantive, the challenges facing kidney patients, improving access to dialysis and more.

Ever wondered what one of the world’s top oncology leaders believes to be the next big thing in cancer care? Find out in our interview AstraZeneca’s Dr Sunil Verma.

What key compliance considerations should pharma companies keep in mind before releasing new research in the US market, and how can they avoid compliance pitfalls?

Video is a powerful tool because it extends the reach of a live event, but does a recording ever live up to the event itself? Enter 3D interactive video.

AI is becoming less of a buzzword for those in the pharma industry. For medical affairs teams, how will it transform the function’s future?

If you want to engage HCPs, you must deliver high-quality medical education. But are all companies taking advantage of interactive quizzes?

A US congress is the place to put your drug on the map, but is this landscape the home of great customer experience for HCPs?

In today’s fast-paced pharma industry, it is vital for companies to provide an excellent customer experience for healthcare professionals.

Hear from four pharma leaders on the benefits to employees and patients of workplaces that promote inclusivity for the LGBTQ+ community.

A 3D, interactive approach allows pharmaceutical companies to share the latest medical breakthroughs in a more dynamic and engaging way.

Dr Harmony Garges, talks to EMJ GOLD about her decision to join the pharmaceutical industry, treating children with HIV and her views on improving access to HIV treatment.

Learn about how 3D human technology offers pharmaceutical companies a fresh and exciting way to take medical education to new heights.

The journey from approval to patient can be convoluted. How can pharma teams communicate the latest advances to busy healthcare professionals?

Stefan Woxström, Senior Vice President Europe and Canada, AstraZeneca, talks about the need for future-proofing healthcare systems, incentivising innovation and reimbursement.

Finding a way to combat the negative effects of ageing could save healthcare systems millions. Learn whether ageing could be the next big pharma market to take the world by storm.

Robyn Widenmaier (GSK) and Tabetha Sundin (AstraZeneca) discuss whether bids to improve gender parity could be the ticket to change in women’s health.

A new generation of doctors is making their way into the workforce, but is the pharmaceutical industry ready to change its tactics to engage these younger HCPs?

The value of medical affairs is not up for debate, but are companies allocating enough time and resources to make it the strategic function it can be?

A deal ends months of wrangling between the UK government and the ABPI, but what will it mean for the industry and the UK’s bid to become a life sciences superpower?

With compliance and regulatory hoops to jump through, medical affairs teams can be reluctant to try new tactics. This roundtable uncovers their relationship with risk and asks what the future holds.

Peter Ahnesorg, Global Hematology Franchise Head, Roche, talks about his background in biochemistry, his hopes for the haematology space and his approach to leadership.

Discover the past and future of hematology. Uncover the challenges, advancements, and the industry’s commitment to patient well-being.

Read about the role the pharma industry can play in ensuring patients can access the right information about medical conditions and medicines.

Dr Andreas Konieczny, Vice President and Head of Medical Affairs Europe, ImmunoGen, talks to GOLD about moving from big pharma to biotech, his passion for oncology and lessons in leadership.

The Irish pharmaceutical sector is expanding. Read more about what is driving companies to channel investment into the Emerald Isle.

To mark World Heart Day 2023, how can the industry strike a balance between driving innovation and ensuring access to care for all?

How can companies best leverage their KOLs earlier in the product lifecycle, and how do KOLs themselves want to involved?

Medical affairs and sales teams have distinctly different roles, but aren’t they just two planets orbiting the same sun?

How can medical affairs achieve efficiencies by standardising and modernising its insight gathering processes?

As the UK PMCPA publishes its first social media guidance for pharmaceutical companies, what can they do to avoid traps when it comes to posting online?

The pharmaceutical industry is being urged to take action to bridge the access gap for women with gynaecological cancers, but what steps are needed to change the game?

Karen Pinachyan, Head of Medical Affairs for Europe, CSL Behring, talks to Isabel O’Brien about the power of personalised medicine, overhauling healthcare and why it is key to know your own mind